Parameters | Total (n = 57) | NRP-1 expression level | P value | |
---|---|---|---|---|
Low (n = 34) | High (n = 23) | |||
Gender | 0.862 | |||
 Male | 31 | 19 | 12 |  |
 Female | 26 | 15 | 11 |  |
Age (year) | 0.511 | |||
 < 60 | 35 | 21 | 14 |  |
 ≥ 60 | 22 | 13 | 9 |  |
Tumor grade | 0.015 | |||
 Well | 7 | 6 | 1 |  |
 Moderate | 47 | 26 | 21 |  |
 Poor | 3 | 1 | 2 |  |
Tumor location | 0.396 | |||
 Head | 43 | 28 | 15 |  |
 Body/tail | 14 | 6 | 8 |  |
Tumor size | 0.224 | |||
 < 40 mm | 36 | 22 | 14 |  |
 ≥ 40 mm | 21 | 12 | 9 |  |
T stage | 0.109 | |||
 T1–T2 | 7 | 3 | 4 |  |
 T3 | 28 | 17 | 11 |  |
 T4 | 23 | 14 | 9 |  |
Lymph metastasis | 0.002 | |||
 Negative | 16 | 14 | 2 |  |
 Positive | 41 | 20 | 21 |  |
AJCC staging | 0.044 | |||
 I + II | 26 | 20 | 6 |  |
 III + IV | 31 | 14 | 17 |  |
CA19-9 (U/L) | 0.087 | |||
 < 37 | 22 | 18 | 4 |  |
 ≥ 37 | 35 | 16 | 19 |  |